News ID: 219320
Published: 1036 GMT August 04, 2018

China to add more cancer drugs to reimbursement list

China to add more cancer drugs to reimbursement list

China plans to add a range of cancer drugs to medicines eligible for reimbursement from the government, the official Xinhua news agency said on Saturday.

The report added that negotiations on pricing with manufacturers should be finished by end-September, Reuters reported.

China’s cancer rates have been soaring, driven by growing numbers of people in their sixties, heavy smoking among men and exposure to pollution.

The drugs under discussion treat blood cancers and solid tumors, including colorectal cancer, renal cell carcinoma, lymphoma and chronic myelogenous leukaemia, according to Xinhua.

The news comes after a low-budget Chinese movie released earlier this year told a story about a leukaemia patient who turns to smuggling cheap cancer drugs from India.

The tale struck a chord with Internet users and even the country’s leaders, spotlighting national anxieties about unaffordable hospital care.



Resource: Reuters
Security Key:
Captcha refresh
Page Generated in 0/0860 sec